These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36999123)

  • 21. Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis.
    Willems A; Roeleveld PP; Labarinas S; Cyrus JW; Muszynski JA; Nellis ME; Karam O
    Perfusion; 2021 Jul; 36(5):501-512. PubMed ID: 32862767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.
    Parzy G; Daviet F; Puech B; Sylvestre A; Guervilly C; Porto A; Hraiech S; Chaumoitre K; Papazian L; Forel JM
    Crit Care Med; 2020 Oct; 48(10):e971-e975. PubMed ID: 32618700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.
    Ramanathan K; Shekar K; Ling RR; Barbaro RP; Wong SN; Tan CS; Rochwerg B; Fernando SM; Takeda S; MacLaren G; Fan E; Brodie D
    Crit Care; 2021 Jun; 25(1):211. PubMed ID: 34127027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleeding and Thrombotic Events During Extracorporeal Membrane Oxygenation for Postcardiotomy Shock.
    Melehy A; Ning Y; Kurlansky P; Kaku Y; Fried J; Hastie J; Ciolek A; Brodie D; Eisenberger AB; Sayer G; Uriel N; Takayama H; Naka Y; Takeda K
    Ann Thorac Surg; 2022 Jan; 113(1):131-137. PubMed ID: 33609547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venovenous extracorporeal membrane oxygenation for coronavirus disease 2019 patients: A systematic review and meta-analysis.
    Zhai K; Xu X; Zhang P; Wei S; Li J; Wu X; Gao B; Zhang Y; Li Y
    Perfusion; 2023 Sep; 38(6):1107-1122. PubMed ID: 35608047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hematologic complications on extracorporeal membranous oxygenation in critically ill pediatric patients: A systematic review and meta-analysis.
    Tang W; Zhang WT; Zhang J; Jiang KH; Ge YW; Zheng AB; Wang QW; Xue P; Chen HL
    Thromb Res; 2023 Feb; 222():75-84. PubMed ID: 36603406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
    Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
    Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome.
    Hayakawa M; Takano K; Kayashima M; Kasahara K; Fukushima H; Matsumoto M
    J Atheroscler Thromb; 2021 Apr; 28(4):396-401. PubMed ID: 33116032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombosis and coagulopathy in COVID-19 patients rceiving ECMO: A narrative review of current literature.
    Yusuff H; Zochios V; Brodie D
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):3312-3317. PubMed ID: 35577652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Civile VT; Tinôco JDS; Pascoal PI; Areias LL; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013739. PubMed ID: 35244208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracranial hemorrhage in COVID-19 patients during extracorporeal membrane oxygenation for acute respiratory failure: a nationwide register study report.
    von Stillfried S; Bülow RD; Röhrig R; Meybohm P; Boor P;
    Crit Care; 2022 Mar; 26(1):83. PubMed ID: 35346314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions.
    Gu J; Yu H; Lin D
    Heliyon; 2023 Feb; 9(2):e13530. PubMed ID: 36865472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major Bleeding and Thrombosis Events in COVID-19 Versus Influenza Patients Requiring Extracorporeal Membrane Oxygenation.
    Northam KA; Murray BP; Fischer WA; Charles AG
    ASAIO J; 2022 Jun; 68(6):779-784. PubMed ID: 35184085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced Intracranial Hemorrhage with Anticoagulation Guideline Implementation.
    Duffy V; Schneider B; Deitemyer M; Walczak A; Simsic JM
    J Extra Corpor Technol; 2022 Dec; 54(4):318-323. PubMed ID: 36742028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19.
    Bemtgen X; Zotzmann V; Benk C; Rilinger J; Steiner K; Asmussen A; Bode C; Wengenmayer T; Maier S; Staudacher DL
    J Thromb Thrombolysis; 2021 Feb; 51(2):301-307. PubMed ID: 32653986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: A systematic review.
    Sanfilippo F; Currò JM; La Via L; Dezio V; Martucci G; Brancati S; Murabito P; Pappalardo F; Astuto M
    Artif Organs; 2022 Dec; 46(12):2371-2381. PubMed ID: 35531906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
    Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
    J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of anticoagulation with bivalirudin for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.
    Hanna DJ; Torbic H; Militello M; Strnad K; Krishnan S; Hohlfelder B
    Int J Artif Organs; 2022 Aug; 45(8):688-694. PubMed ID: 35708334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleeding, Thrombosis, and Transfusion With Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients.
    Mazzeffi MA; Tanaka K; Roberts A; Rector R; Menaker J; Kon Z; Deatrick KB; Kaczorowski D; Griffith B; Herr D
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1216-1220. PubMed ID: 30181084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.